Instituto Nacional de Enfermedades Respiratorias

COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study. (2024) Andreoli L, Lini D, Schreiber K, Parodis I, Sen P, Ravichandran N, Day J, et al. Journal article Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys (2023) Jagtap K, Naveen R, Day J, Sen P, Vaidya B, Nune A, Nikiphorou E, et al. Journal article Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study (2023) Ali SS, Naveen R, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys (2023) Sen P, Naveen R, Houshmand N, Kia SM, Joshi M, Saha S, Jagtap K, et al. Journal article Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. (2023) Naveen R, Nikiphorou E, Joshi M, Sen P, Lindblom J, Agarwal V, Lilleker JB, et al. Journal article Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study (2023) Doskaliuk B, Ravichandran N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, et al. Journal article Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD study (2023) Sandhu NK, Ravichandraan N, Nune A, Day J, Sen P, Nikiphorou E, Tan AL, et al. Journal article Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study (2022) Dey M, Naveen R, Nikiphorou E, Sen P, Saha S, Lilleker JB, Agarwal V, et al. Journal article, Letter Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article